This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Alliance Pharma says it made ‘rational commercial’ decisions, in UK fine appeal

By Jon Menon ( July 27, 2023, 15:22 GMT | Insight) -- Alliance Pharmaceuticals has hit back at suggestions it had colluded to break UK competition rules, as several drugmakers begin to close their appeal against fines imposed by the antitrust regulator. Alliance, Focus, Medreich and Lexon were fined a total of more than 35 million pounds ($43 million) last year by the Competition and Markets Authority, which said that their behavior resulted in soaring prices of a nausea drug for the state-funded National Health Service.Alliance Pharmaceuticals has hit back at suggestions it had colluded to break UK competition rules, as several drugmakers begin to close their appeal against fines imposed by the antitrust regulator....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections